Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

PZ-II-029

Copy Product Info
🥰Excellent
Catalog No. T28479Cas No. 164025-44-9
Alias PZII-029, PZ-II029, PZII029, PZ II-029, PZ II029

PZ-II-029 is a modulator of α6β3γ2-selective GABAA channel.

PZ-II-029

PZ-II-029

Copy Product Info
🥰Excellent
Purity: 99.79%
Catalog No. T28479Alias PZII-029, PZ-II029, PZII029, PZ II-029, PZ II029Cas No. 164025-44-9
PZ-II-029 is a modulator of α6β3γ2-selective GABAA channel.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$48In StockIn Stock
5 mg$113In StockIn Stock
10 mg$179In StockIn Stock
25 mg$322In StockIn Stock
50 mg$496In StockIn Stock
100 mg$762In StockIn Stock
500 mg$1,530In StockIn Stock
1 mL x 10 mM (in DMSO)$213In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.79%
Appearance:Solid
Color:Yellow
Contact us for more batch information

Resource Download

Product Introduction

PZ-II-029 AI Summary
PZ-II-029 exhibits significant pharmacokinetic and pharmacodynamic properties. Pharmacokinetically, it demonstrates metabolic stability in both human and mouse liver microsomes, characterized by specific half-lives and remaining percentages of the parent compound after certain durations. It also varies in solubility levels across different solutions. Pharmacodynamically, PZ-II-029 acts as a positive allosteric modulator on GABA-A receptors, especially showing enhanced potentiation on the alpha6beta3gamma2 subunit compared to other subunits. This effect leads to increased GABA-induced current amplitudes at specific holding potentials, with enhancement reaching up to 702% at varying concentrations. In vivo studies in Wistar rats indicate crucial parameters such as Cmax, Tmax, AUC, and terminal elimination half-life in both plasma and brain compartments, following different administration routes. Additionally, the compound demonstrates a brain-to-plasma AUC ratio and oral bioavailability in both plasma and brain after oral gavage administration..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
PZ-II-029 is a modulator of α6β3γ2-selective GABAA channel.
SynonymsPZII-029, PZ-II029, PZII029, PZ II-029, PZ II029
Chemical Properties
Molecular Weight321.33
FormulaC18H15N3O3
Cas No.164025-44-9
SmilesO=C1C=2C(C=3C(NC2)=CC(OC)=CC3)=NN1C4=CC=C(OC)C=C4
Relative Density.1.35 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 50 mg/mL (155.6 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.1121 mL15.5603 mL31.1207 mL155.6033 mL
5 mM0.6224 mL3.1121 mL6.2241 mL31.1207 mL
10 mM0.3112 mL1.5560 mL3.1121 mL15.5603 mL
20 mM0.1556 mL0.7780 mL1.5560 mL7.7802 mL
50 mM0.0622 mL0.3112 mL0.6224 mL3.1121 mL
100 mM0.0311 mL0.1556 mL0.3112 mL1.5560 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy PZ-II-029 | purchase PZ-II-029 | PZ-II-029 cost | order PZ-II-029 | PZ-II-029 chemical structure | PZ-II-029 formula | PZ-II-029 molecular weight